Keywords: Shire, Movetis, mergers and acquisitions, pharma

Shire buying Movetis for $558 million to expand specialist gastrointestinal portfolio

Article | 04 August 2010

Dublin, Ireland-based specialty biopharmaceutical company Shire revealed yesterday that it will launch a voluntary public takeover offer for all the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Movetis

Shire

Go to company listing

Related Drugs

Resolor

Go to drug listing